chuminhua2019-01-03 23:08
$Ohr制药(OHRP)$
12/3,NeuBase Therapeutics通过反向收购Ohr Pharmaceutical,在纳斯达克上市。NeuBase的模块化反义肽核酸(PNA)平台PATrOL用于改善基因沉默疗法。网页链接查看全文
$Ohr制药(OHRP)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2019-06-06 AccNo: 0001387131-19-004248 Size: 5 MB 网页链接
$Ohr制药(OHRP)$ S-4/A [Amend] - Registration of securities, business combinations Filed: 2019-06-03 AccNo: 0001387131-19-004175 Size: 5 MB 网页链接
$Ohr制药(OHRP)$ S-4/A [Amend] - Registration of securities, business combinations Filed: 2019-05-22 AccNo: 0001387131-19-003888 Size: 9 MB 网页链接
$Ohr制药(OHRP)$ 425 - Prospectuses and communications, business combinations Filed: 2019-05-15 AccNo: 0001387131-19-003727 Size: 62 KB 网页链接
$Ohr制药(OHRP)$ 8-K - Current report Filed: 2019-05-15 AccNo: 0001387131-19-003726 Size: 61 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Ohr制药(OHRP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-15 AccNo: 0001387131-19-003729 Size: 1 MB 网页链接
$Ohr制药(OHRP)$ S-4/A [Amend] - Registration of securities, business combinations Filed: 2019-05-07 AccNo: 0001387131-19-003388 Size: 6 MB 网页链接
$Ohr制药(OHRP)$ S-4/A [Amend] - Registration of securities, business combinations Filed: 2019-04-16 AccNo: 0001387131-19-002690 Size: 5 MB 网页链接
$Ohr制药(OHRP)$ S-4 - Registration of securities, business combinations Filed: 2019-03-08 AccNo: 0001387131-19-001802 Size: 9 MB 网页链接
$Ohr制药(OHRP)$ 8-K - Current report Filed: 2019-02-26 AccNo: 0001387131-19-001453 Size: 30 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接